method fortreatment of pleural effusion of unclear origin complicated by pericardial effusion

• 1. 用于心包积液治疗并预防并发症的药物组合物 [P] . 中国专利： CN106166148A . 2016-11-30
• 2. 化合物或其盐、抗炎症剂、针对肺癌的抗癌剂、化合物或其盐的制造方法、炎症性疾病的治疗方法及肺癌的治疗方法 [P] . 中国专利： CN110121560A . 2019-08-13
• 3. RECOMBINANT INTERFERON WITH CHANGED SPATIAL CONFIGURATION FOR USE IN THE TREATMENT OF MALIGNANT PLEURAL EFFUSION, MALIGNANT ASCITES, AND/OR MALIGNANT PERICARDIAL EFFUSION [P] . EP2941264B1 . 2021-03-10

  机译： 重组干扰素具有改变的空间构型，用于治疗恶性胸腔积液，恶性腹水和/或恶性心包积液

• 4. METHOD FOR MORPHOLOGICAL ASSESSMENT OF DURATION OF PLEURAL TUBERCULOSIS COMPLICATED BY EFFUSION [P] . UA24364U . 2007-06-25

  机译： 融合引起的合并肺结核持续时间的形态学评估方法

• 5. Method of operation of a cooling device, or sweating effusion and pericardial effusion, provided with a cooling or sweating [P] . 法国专利： FR2955899B1 . 2016-12-09

  机译： 带有冷却或出汗的冷却装置或出汗和心包积液的操作方法

• 1. Comparison of intra-pleural injection efficacy between Endostar and Bevacizumab combined with pemetrexed/cisplatin for the treatment of malignant pleural effusion in patients with epidermal growth factor receptor-/anaplastic lymphoma kinase-lung adenocarci [J] . Yi Cheng, Nan Huang, Kai Qin, 肿瘤学与转化医学（英文） . 2019,第002期
• 2. Effect of intrapleural endostatin and mannatide infusion on malignant molecule expression in pleural fluid of malignant pleural effusion [J] . Juan Kang 海南医科大学学报（英文版） . 2017,第002期
• 3. Effect of intrapleural endostatin and mannatide infusion on malignant molecule expression in pleural fluid of malignant pleural effusion [J] . Juan Kang 海南医科大学学报(英文版) . 2017,第002期
• 4. RECURRENT PERICARDIAL EFFUSIONS AND PLEURAL EFFUSION: WHAT ARE WE MISSING? A RARE CASE OF PRIMARY PERICARDIAL MALIGNANT MESOTHELIOMA [J] . SANJANA KASHINATH, SOWJANYA VUYYALA, BASARAT BAIG, Chest: The Journal of Circulation, Respiration and Related Systems . 2018,第4期
• 5. RECURRENT PERICARDIAL EFFUSIONS AND PLEURAL EFFUSION: WHAT ARE WE MISSING? A RARE CASE OF PRIMARY PERICARDIAL MALIGNANT MESOTHELIOMA [J] . SANJANA KASHINATH, SOWJANYA VUYYALA, BASARAT BAIG, Chest: The Journal of Circulation, Respiration and Related Systems . 2018,第4期
• 6. A Case of Congenital Lymphedema Complicated by Chronic Chylous Effusions and Recurrent Pericardial Effusion Requiring Pericardial Window [J] . Abdulrahman Katabi, Mohammed Al-Ourani, Fuad Zeid Cureus. . 2020,第5期
• 7. Evaluation of pleural, peritoneal, and pericardial effusions [C] . Alan H.Rebar Conference of the North American Veterinary . 1998
• 8. The usefulness of pleural fluid presepsin, C-reactive protein, and procalcitonin in distinguishing different causes of pleural effusions [D] . 渡邊 直樹 2019
• 9. A Simple Method for Differentiating Complicated Parapneumonic Effusion/Empyema from Parapneumonic Effusion Using the Split Pleura Sign and the Amount of Pleural Effusion on Thoracic CT [O] . Naoki Tsujimoto, Takeshi Saraya, Richard W. Light, -1
• 10. A Simple Method for Differentiating Complicated Parapneumonic Effusion/Empyema from Parapneumonic Effusion Using the Split Pleura Sign and the Amount of Pleural Effusion on Thoracic CT. [O] . Naoki Tsujimoto, Takeshi Saraya, Richard W Light, 2015

• 1. Clinical Value of Vascular Endothelial Growth Factor Combined with Interferon-γ in Diagnosing Malignant Pleural Effusion and Tuberculous Pleural Effusion [J] . XUE Keying ,XIONG Shengdao ,XIONG Weining . 华中科技大学学报（医学）（英德文版） . 2007,第005期
• 2. Clinical Application of T-SPOT.TB Using Pleural Effusion as a Diagnostic Method for Tuberculosis Infection [J] . Yoshihiro Kobashi ,Keiji Mouri ,Yasushi Obase . 呼吸病期刊（英文） . 2014,第2期
• 3. 肿瘤晚期并发恶性心包积液患者的护理 [C] . 王婉云 ,王玉巧 . 第14届全国老年护理学术交流会议 . 2011
• 4. 急性ST段抬高型心肌梗死并发心包积液的相关因素及其对患者预后的影响 [A] . 闫宇 . 2019